Endostatin's antiangiogenic signaling network

被引:362
|
作者
Abdollahi, A
Hahnfeldt, P
Maercker, C
Gröne, HJ
Debus, J
Ansorge, W
Folkman, J
Hlatky, L
Huber, PE
机构
[1] Univ Heidelberg, Sch Med, Dept Radiat Oncol, German Canc Res Ctr, Heidelberg, Germany
[2] Univ Heidelberg, Sch Med, Dept Radiat Oncol, Heidelberg, Germany
[3] Harvard Univ, Sch Med, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA USA
[4] German Genome Resource Ctr, Berlin, Germany
[5] German Canc Res Ctr, Dept Mol Pathol, D-6900 Heidelberg, Germany
[6] European Mol Biol Lab, Heidelberg, Germany
[7] Harvard Univ, Sch Med, Surg Res Lab, Dept Surg,Childrens Hosp, Boston, MA 02115 USA
[8] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[9] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
关键词
D O I
10.1016/S1097-2765(04)00102-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It is here demonstrated that the set of gene expressions underlying the angiogenic balance in tissues can be molecularly reset en masse by a single protein. Using genome-wide expression profiling, coupled with RT-PCR and phosphorylation analysis, we show that the endogenous angiogenesis inhibitor endostatin down-regulates many signaling pathways in human microvascular endothelium associated with proangiogenic activity. Simultaneously, endostatin is found to upregulate many antiangiogenic genes. The result is a unique alignment between the direction of gene regulation and angiogenic status. Profiling further reveals the regulation of genes not heretofore associated with angiogenesis. Our analysis of coregulated genes shows complex interpathway communications in an intricate signaling network that both recapitulates and extends on current understanding of the angiogenic process. More generally, insights into the nature of genetic networking from the cell biologic and therapeutic perspectives are revealed.
引用
收藏
页码:649 / 663
页数:15
相关论文
共 50 条
  • [21] Cellular actions and signaling by endostatin
    Ramchandran, R
    Karumanchi, SA
    Hanai, J
    Alper, SL
    Sukhatme, VP
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2002, 12 (03): : 175 - 191
  • [22] The interaction between the antiangiogenic endostatin and endothelial cell heparan sulphate.
    Blackhall, FH
    Merry, CL
    Henrioud, A
    Deakin, JA
    Park, S
    Javaherian, K
    Folkman, J
    Gallagher, JT
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3665S - 3665S
  • [23] Endostatin, an antiangiogenic protein, is expressed in the unilateral ureteral obstruction mice model
    Maciel, Thiago T.
    Coutinho, Enia L.
    Soares, Debora
    Achar, Eduardo
    Schor, Nestor
    Bellini, Maria H.
    JOURNAL OF NEPHROLOGY, 2008, 21 (05) : 753 - 760
  • [24] Assessment of antiangiogenic effect using 99mTc-EC-endostatin
    Yang, DJ
    Kim, KD
    Schechter, NR
    Yu, DF
    Wu, P
    Azhdarinia, A
    Roach, JS
    Kalimi, SK
    Ozaki, K
    Fogler, WE
    Bryant, JL
    Herbst, R
    Abbruzzes, J
    Kim, EE
    Podoloff, DA
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (02) : 233 - 246
  • [25] ANTIANGIOGENIC GENE THERAPY ON HEPATOCELLULAR CARCINOMA USING ENDOSTATIN AND SONOPORATION IN VIVO
    Tsai, Kun-Che
    Liao, Zhe-Kang
    Lin, Win-Li
    Shieh, Ming-Jium
    Hwang, Lih-Hwa
    Chen, Wen-Shiang
    BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS, 2010, 22 (01): : 71 - 79
  • [26] A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model
    Suzaki, Y
    Hamada, K
    Sho, M
    Ito, T
    Miyamoto, K
    Akashi, S
    Kashizuka, H
    Ikeda, N
    Nakajima, Y
    Iwase, M
    Homma, I
    Kobzik, L
    Kimura, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (06) : 1220 - 1227
  • [27] Antiangiogenic activity of endostatin inhibits C6 glioma growth
    Peroulis, I
    Jonas, N
    Saleh, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) : 839 - 845
  • [28] FaDu xenografts: No modulation of growth kinetics via antiangiogenic therapy with endostatin
    Classen, J
    Paulsen, F
    Hehr, T
    Bamberg, M
    Budach, W
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 14 - 14
  • [29] Assessment of antiangiogenic effect with Tc-99m labeled endostatin
    Kim, E
    Yang, DJ
    Herbst, R
    Yu, D
    Podoloff, DA
    RADIOLOGY, 2001, 221 : 291 - 291
  • [30] Antiangiogenic Drugs: Insights into Drug Development from Endostatin, Avastin and Thalidomide
    Holaday, John W.
    Berkowitz, Barry A.
    MOLECULAR INTERVENTIONS, 2009, 9 (04) : 157 - 166